Diamyd Medical
banner
diamyd.com
Diamyd Medical
@diamyd.com
Diamyd Medical is a swedish clinical-stage diabetes company active in the field of pharmaceutical development. 💙

Diamyd Medical’s shares are traded on Nasdaq First North Growth Market, ticker $DMYD B

www.diamyd.com
📹 9.00 presenterar Diamyd Medical vid G&W Småbolagsfrukost

ir.financialhearings.com/gw-smabolags...
April 11, 2024 at 6:55 AM
🎧 PODCAST - #Diabetes Daily Grind in a conversation on Diamyd Medicals pioneering investigational immunotherapy, currently undergoing phase-III clinical trials.

diabetesdailygrind.com/unearthing-d...
Unearthing Diabetes Discoveries #1 | Ulf Hannelius, Diamyd Medical
Welcome to Unearthing Diabetes Discoveries, your inside look at cutting-edge diabetes research. In this episode, I chat with Ulf Hannelius, CEO of Diamyd Medical, about their groundbreaking investigat...
diabetesdailygrind.com
March 12, 2024 at 10:18 AM
How can AI improve T1D screening?

✍️Check article published in Diabetologia, the authoritative journal dedicated to the study of #diabetes.
link.springer.com/content/pdf/...
link.springer.com
February 20, 2024 at 2:33 PM
Trading Direkt Healthcare: "Forskningsbolaget Diamyd Medical har beviljats snabbehandlingsstatus av den amerikanska läkemedelsmyndigheten FDA för sin vaccinkandidat Diamyd inom området för typ 1-diabetes."

$DMYDB
Trading Direkt Healthcare 2024-02-19 | Kvartalsrapporter från Bioarctic och Camurus
00:00 Intro00:48 Uppdatering om Bioarctic efter bokslutet 202305:24 Synen på specialistläkemedelsbolaget Camurus bokslut 202310:09 Nedskrivningen av goodwill...
www.youtube.com
February 19, 2024 at 12:52 PM
🎥 Live broadcast 19/2 at 16:00 CET with @diamyd.com CEO & board member, discussing the @fda.gov granted Fast Track designation & its implications for the development of the antigen-specific immunotherapy for type 1 #diabetes.
Chat open for questions. Welcome! 💙 youtube.com/live/GzWKvOM...
Diamyd Medical | Live 16:00 (CET) Diamyd comment on FDA Fast Track designation granted
President & CEO, Ph.D Ulf Hannelius and board member MD & Ph.D Karin Rosén participates. Viewers can ask questions in the live chat.
youtube.com
February 19, 2024 at 7:20 AM
We are very pleased with the @fda.gov decision to grant Fast Track designation for #Diamyd and the potential this provides to accelerate Diamyd’s path to entering the US market", says Ulf Hannelius, CEO of Diamyd Medical. 💙
February 15, 2024 at 10:44 AM